Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1984 Mar;49(3):337–342. doi: 10.1038/bjc.1984.53

A new indicator of human malignant tumour.

S Metcalfe, J Milner, R J Svvennsen
PMCID: PMC1976744  PMID: 6704310

Abstract

In haemagglutination tests we have found that the monoclonal antibody B5 discriminates between erythrocytes from patients with malignant cancer (total 386; greater than 80% B5 positive) and individuals with no known tumour (total 247; less than 20% B5 positive). The B5 antigen detected on intact erythrocytes is a tightly bound surface component which does not appear to be derived from the plasma. The B5 antigen is not T, Tn, Ca1, CEA or the Forsmann antigen; nor is it related to any of the major blood group antigens. Abnormal levels of surface B5 are found on erythrocytes from patients with a great diversity of tumours and this fact presents B5 as an indirect marker of malignancy. Successful eradication of tumour is associated with a switch from positive to negative B5 haemagglutination. We believe that B5 is a valuable addition to the few useful tumour markers already employed for monitoring tumour status.

Full text

PDF
337

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Galfrè G., Milstein C., Wright B. Rat x rat hybrid myelomas and a monoclonal anti-Fd portion of mouse IgG. Nature. 1979 Jan 11;277(5692):131–133. doi: 10.1038/277131a0. [DOI] [PubMed] [Google Scholar]
  2. Milner J., Metcalfe S. Monoclonal antibody which agglutinates erythrocytes from cancer patients. Lancet. 1982 Nov 13;2(8307):1100–1101. doi: 10.1016/s0140-6736(82)90026-5. [DOI] [PubMed] [Google Scholar]
  3. Postolov P. M., Rustamov G. A., Kuzin N. M., Zavodnov V. Ia. Vliianie selektivnoi proksimal'noi vagotomii na zashchitnyi bar'er slizistoi obolochki zheludka. Khirurgiia (Mosk) 1982 Mar;(3):6–10. [PubMed] [Google Scholar]
  4. Springer G. F., Desai P. R., Banatwala I. Blood group MN antigens and precursors in normal and malignant human breast glandular tissue. J Natl Cancer Inst. 1975 Feb;54(2):335–339. [PubMed] [Google Scholar]
  5. Springer G. F., Desai P. R. Human blood-group MN and precursor specificities: structural and biological aspects. Carbohydr Res. 1975 Mar;40(1):183–192. doi: 10.1016/s0008-6215(00)82680-4. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES